Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
BMC Neurol ; 24(1): 112, 2024 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-38580923

RESUMEN

BACKGROUND: Streptococcus intermedius is a member of the S. anginosus group and is part of the normal oral microbiota. It can cause pyogenic infections in various organs, primarily in the head and neck area, including brain abscesses and meningitis. However, ventriculitis due to periodontitis has not been reported previously. CASE PRESENTATION: A 64-year-old male was admitted to the hospital with a headache, fever and later imbalance, blurred vision, and general slowness. Neurological examination revealed nuchal rigidity and general clumsiness. Meningitis was suspected, and the patient was treated with dexamethasone, ceftriaxone and acyclovir. A brain computer tomography (CT) scan was normal, and cerebrospinal fluid (CSF) Gram staining and bacterial cultures remained negative, so the antibacterial treatment was discontinued. Nine days after admission, the patient's condition deteriorated. The antibacterial treatment was restarted, and a brain magnetic resonance imaging revealed ventriculitis. A subsequent CT scan showed hydrocephalus, so a ventriculostomy was performed. In CSF Gram staining, chains of gram-positive cocci were observed. Bacterial cultures remained negative, but a bacterial PCR detected Streptococcus intermedius. An orthopantomography revealed advanced periodontal destruction in several teeth and periapical abscesses, which were subsequently operated on. The patient was discharged in good condition after one month. CONCLUSIONS: Poor dental health can lead to life-threatening infections in the central nervous system, even in a completely healthy individual. Primary bacterial ventriculitis is a diagnostic challenge, which may result in delayed treatment and increased mortality.


Asunto(s)
Infecciones Bacterianas del Sistema Nervioso Central , Ventriculitis Cerebral , Meningitis , Periodontitis , Masculino , Humanos , Persona de Mediana Edad , Streptococcus intermedius , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/diagnóstico por imagen , Ventriculitis Cerebral/tratamiento farmacológico , Antibacterianos/uso terapéutico , Meningitis/diagnóstico , Periodontitis/complicaciones , Periodontitis/tratamiento farmacológico
2.
Eur Stroke J ; 8(1): 301-308, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-37021154

RESUMEN

Introduction: Hydrocephalus after aneurysmal subarachnoid haemorrhage (aSAH) is a common complication which may lead to insertion of a ventriculoperitoneal shunt (VPS). Our aim is to evaluate a possible influence of specific clinical and biochemical factors on VPS dependency with special emphasis on hyperglycaemia on admission. Patients and methods: Retrospective analysis of a monocentric database of aSAH patients. Using univariable and multivariable logistic regression analysis we evaluated factors influencing VPS dependency, with a special focus on hyperglycaemia on blood sample within 24 h of admission, dichotomised at 126 mg/dl. Factors evaluated in the univariable analysis were age, sex, known diabetes, Hunt and Hess grade, Barrow Neurological Institute scale, treatment modality, extra-ventricular drain (EVD) insertion, complications (rebleeding, vasospasm, infarction, decompressive craniectomy, ventriculitis), outcome variables and laboratory parameters (glucose, C-reactive protein, procalcitonin). Results: We included 510 consecutive patients treated with acute aSAH requiring a VPS (mean age 58.2 years, 66% were female). An EVD was inserted in 387 (75.9%) patients. In the univariable analysis, VPS dependency was associated with hyperglycaemia on admission (OR 2.56, 95%CI 1.58-4.14, p < 0.001). In the multivariable regression analysis after stepwise backward regression, factors associated with VPS dependency were hyperglycaemia >126 mg/dl on admission (OR 1.93, 95%CI 1.13-3.30, p = 0.02), ventriculitis (OR 2.33, 95%CI 1.33-4.04, p = 0.003), Hunt and Hess grade (overall p-value 0.02) and decompressive craniectomy (OR 2.68, 95%CI 1.55-4.64, p < 0.001). Conclusion: Hyperglycaemia on admission was associated with an increased probability of VPS placement. If confirmed, this finding might facilitate treatment of these patients by accelerating insertion of a permanent draining system.


Asunto(s)
Ventriculitis Cerebral , Gastritis , Hiperglucemia , Hemorragia Subaracnoidea , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ventriculitis Cerebral/complicaciones , Gastritis/complicaciones , Hiperglucemia/complicaciones , Estudios Retrospectivos , Hemorragia Subaracnoidea/complicaciones , Derivación Ventriculoperitoneal/efectos adversos
3.
Childs Nerv Syst ; 38(11): 2155-2162, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-36214898

RESUMEN

BACKGROUND: The management of post-infectious hydrocephalus (PIH) remains challenging for neurosurgeons. It requires a temporary diversion procedure till the normalization of CSF parameters prior to the permanent one. Ventriculosubgaleal shunt (VSGS) was widely used in pediatric cases with post-hemorrhagic hydrocephalus (PHH). However, its role in PIH is still lacking. This study was done to elucidate the safety and efficacy of VSGS as a temporary CSF diversion procedure before the permanent one in patients with PIH. PATIENTS AND METHODS: This retrospective investigation analyzed the data of 50 consecutive cases who underwent VSGS for PIH. RESULTS: The age of the included patients ranged between 1 and 10 months. Twenty-six cases had meningitis and or ventriculitis (52%), while the remaining had shunt infection. At follow-up, arresting of hydrocephalus was noted in ten patients (20%), while another 36 cases required the permanent diversion procedure within 35 days. Regarding the shunt complications, scalp infection, tissue breakdown, and shunt exposure were encountered in ten cases (20%), while CSF leakage was noted in 12 cases (24%). Shunt migration was noted in only two patients (4%). Shunt revision was needed in 16 cases (32%). Mortality was encountered in four cases (8%) because of sepsis. Risk factors for morbimortality included younger age, lower weight, male gender, and meningitis and or ventriculitis. CONCLUSION: VSGS is a safe and effective procedure in infants awaiting definitive VPS for postinfectious hydrocephalus. It was proven that VSGS has shortened the hospital stay and the economic burden on the country.


Asunto(s)
Ventriculitis Cerebral , Hidrocefalia , Meningitis , Lactante , Humanos , Masculino , Niño , Estudios Retrospectivos , Ventriculitis Cerebral/complicaciones , Derivaciones del Líquido Cefalorraquídeo/métodos , Hidrocefalia/etiología , Hidrocefalia/cirugía , Meningitis/etiología , Derivación Ventriculoperitoneal/efectos adversos
4.
BMJ Case Rep ; 15(2)2022 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-35228235

RESUMEN

It has long been believed that spinal subdural empyemas (SDEs) with neurological symptoms result in death if operative intervention is not performed. We present a case of addressing an extensive spinal SDE with a minimally invasive procedure: a bedside lumbar drain. Our patient is a 67-year-old man with medical history significant for type I diabetes who presented 2 weeks after a right shoulder steroid injection with septic arthritis. An MRI was obtained for back pain which revealed spinal SDE from the cervical to lumbosacral spine. Given patient's acute sepsis, haemodynamic instability, and extent of empyema, we placed a lumbar drain for decompression. The patient had a prolonged complicated hospital course. Imaging 2 months later revealed interval decrease in the spinal SDE. Although this severe septic event left the patient with significant deficits, he was able to return to ambulation without surgical intervention.


Asunto(s)
Ventriculitis Cerebral , Empiema Subdural , Enfermedades de la Médula Espinal , Anciano , Dolor de Espalda/complicaciones , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/tratamiento farmacológico , Empiema Subdural/etiología , Humanos , Región Lumbosacra , Masculino , Enfermedades de la Médula Espinal/complicaciones
5.
N Z Vet J ; 70(4): 238-243, 2022 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-35317706

RESUMEN

CASE HISTORY: A 1-year-old Border Terrier presented with acute onset of neurological signs and neck pain. CLINICAL FINDINGS: Severe generalised ataxia, muscle tremors and cranial nerve deficits were noted. Multifocal brain lesions were suspected based on neurological examination. Computed tomography revealed an abdominal mass and cerebellar herniation through the foramen magnum. LABORATORY AND PATHOLOGICAL FINDINGS: Cytological and histopathological analysis of the abdominal mass revealed necrotising and granulomatous lymphadenitis with intralesional algal elements most consistent with Prototheca spp.. Culture of a sample from the mesenteric lymph node confirmed the presence of Prototheca spp. which was identified as P. bovis based on sequencing of a DNA fragment amplified by PCR. Following inadequate response to symptomatic therapy and poor prognosis, the dog was subjected to euthanasia. Histopathological evaluation of the central nervous system lesions, identified granulomatous meningitis and ventriculitis with the presence of intralesional algae. DIAGNOSIS: Disseminated protothecosis with granulomatous meningitis and ventriculitis caused by Prototheca bovis (formerly P. zopfii gen. 2). CLINICAL RELEVANCE: This is the first case report of disseminated protothecosis with central nervous system involvement in a dog in New Zealand.


Asunto(s)
Ventriculitis Cerebral , Enfermedades de los Perros , Infecciones , Prototheca , Animales , Sistema Nervioso Central/patología , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/veterinaria , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/etiología , Perros , Infecciones/diagnóstico , Infecciones/patología , Infecciones/veterinaria , Nueva Zelanda/epidemiología , Prototheca/genética , Enfermedades Cutáneas Infecciosas
7.
No Shinkei Geka ; 48(12): 1121-1128, 2020 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-33353874

RESUMEN

Multiloculated hydrocephalus following severe meningitis with ventriculitis is often therapeutically challenging. Neonatal meningitis is commonly associated with ventricular inflammation, and approximately 30% of patients show septum formation. Although placement of a single ventriculoperitoneal shunt system could serve as optimal treatment for a multiloculated cerebrospinal cavity that is converted into a single chamber, multiple devices are often required for disease stability. We report a case of multiloculated hydrocephalus that occurred after meningitis in a patient who was successfully treated with a single shunt system using staged multimodality treatments.


Asunto(s)
Ventriculitis Cerebral , Hidrocefalia , Meningitis , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/diagnóstico por imagen , Derivaciones del Líquido Cefalorraquídeo , Humanos , Hidrocefalia/diagnóstico por imagen , Hidrocefalia/etiología , Hidrocefalia/cirugía , Meningitis/complicaciones , Meningitis/cirugía , Derivación Ventriculoperitoneal
8.
Medicine (Baltimore) ; 99(34): e21751, 2020 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-32846799

RESUMEN

INTRODUCTION: Chryseobacterium arthrosphaerae is a gram-negative bacteria, known for its intrinsic multidrug resistance, which can lead to treatment difficulties. PATIENT CONCERNS: A 56-year-old male had an indwelling external ventricular drainage catheter for 6 months and had been frequently treated with antibiotics for nosocomial infections. He showed cerebrospinal fluid pleocytosis and an abrupt fever during hospitalization. DIAGNOSIS: He was diagnosed as a ventriculitis caused by Chryseobacterium arthrosphaerae (C arthrosphaerae). INTERVENTION: Initially, we used ciprofloxacin as the backbone in combination with minocycline (and rifampin). However, fever and pleocytosis persisted, and improvement was slow. We then switched the minocycline and rifampin regiment to trimethoprim/sulfamethoxazole. Following this switch of antibiotics, the patient's pleocytosis rapidly improved, allowing the replacement of his external ventricular drainage catheters. C arthrospharae was no longer growing in cerebrospinal fluid and he was recovered from ventriculitis. OUTCOMES: The patient remains alive without any incidence of C arthrosphaerae recurrence. CONCLUSION: We propose trimethoprim/sulfamethoxazole alone or in combination with ciprofloxacin to be good candidates for the treatment of ventriculitis by C arthrosphaerae.


Asunto(s)
Antibacterianos/uso terapéutico , Ventriculitis Cerebral/tratamiento farmacológico , Chryseobacterium , Antibacterianos/administración & dosificación , Catéteres de Permanencia , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/diagnóstico , Drenaje , Quimioterapia Combinada , Humanos , Leucocitosis/etiología , Masculino , Persona de Mediana Edad , Minociclina/uso terapéutico , Rifampin/uso terapéutico , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico
9.
Clin Neurol Neurosurg ; 188: 105592, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31760254

RESUMEN

A 38-year-old male presented to the hospital with headache, fever, and meningeal signs. He had undergone a surgical review of a ventriculoperitoneal shunt system one month earlier. A head computed tomography scan showed hydrocephalus. His medical history included a human immunodeficiency virus infection identified four years before and resolved cryptococcal meningitis, which had necessitated the implantation of the shunt system. Ventricular cerebrospinal fluid (CSF) was obtained, which showed inflammation and, in culture, grew a Gram-negative bacillus identified as multidrug-resistant Klebsiella oxytoca. The shunt was removed and a ventricular drain was installed. Treatment with meropenem and amikacin was established without a response; the CSF white blood cell count continued to increase, with cultures remaining positive. The patient's clinical condition deteriorated to stupor. With informed consent, intraventricular (ITV) treatment with tigecycline was initiated at a dose of 5 mg every 24 h and, three days later, the CSF cultures were negativized. Tigecycline levels in the CSF were quantified by liquid chromatography with ultraviolet detection and showed peak concentrations achieved at two hours after the dose of between 178 and 310 µg/mL. After 11 days of treatment with ITV tigecycline and eight negative CSF cultures, a new CSF shunt was installed. During follow-up review 10 months later, the patient reported he was working. The dose of tigecycline used in this study produced levels 15 to 20 times the minimum inhibitory concentration of the bacteria for up to six hours with adequate tolerance.


Asunto(s)
Antibacterianos/uso terapéutico , Ventriculitis Cerebral/tratamiento farmacológico , Farmacorresistencia Bacteriana Múltiple , Infecciones por Klebsiella/tratamiento farmacológico , Infección de la Herida Quirúrgica/tratamiento farmacológico , Tigeciclina/uso terapéutico , Derivación Ventriculoperitoneal , Adulto , Antibacterianos/líquido cefalorraquídeo , Fármacos Anti-VIH/uso terapéutico , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/diagnóstico , Ventriculitis Cerebral/microbiología , Combinación Efavirenz, Emtricitabina y Fumarato de Tenofovir Disoproxil/uso terapéutico , Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Humanos , Inyecciones Intraventriculares , Infecciones por Klebsiella/complicaciones , Infecciones por Klebsiella/diagnóstico , Infecciones por Klebsiella/microbiología , Klebsiella oxytoca/aislamiento & purificación , Klebsiella oxytoca/fisiología , Masculino , Pruebas de Sensibilidad Microbiana , Infección de la Herida Quirúrgica/complicaciones , Infección de la Herida Quirúrgica/diagnóstico , Infección de la Herida Quirúrgica/microbiología , Tigeciclina/líquido cefalorraquídeo
10.
Childs Nerv Syst ; 35(11): 2205-2210, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31289854

RESUMEN

PURPOSE: To describe the profile and determine the risk factors for the development of intracranial infections (ICI) in paediatric patients with myelomeningocele (MMC). METHODS: Retrospective analysis of data from the records of patients with MMC admitted into our hospital between January 2006 and December 2015. RESULTS: We managed a total of 688 paediatric non-trauma neurosurgical patients in our facility during the study period. 29.4% of these patients had MMC. We found the records for 49% of the patients. The male: female ratio was 1.3:1. Most of the MMCs were located in the lumbosacral region (71.7%). The lesion was ruptured in 42.4%, unruptured in 53.5%, and indeterminate in 4.0% of the patients. 48.5% of the MMCs were infected at presentation. Surgical repair of the spinal dysraphism was performed in 74.7% of the patients. Postoperative complications observed in our series include wound dehiscence, cerebrospinal fluid leak, and pseudomeningocele which occurred in 13.5%, 12.2%, and 2.7% of the operated cases of MMC respectively. 28.3% of the patients with MMC developed ICI during the course of hospitalization. 71.4% of patients with MMC-associated ICI had septic neural placode at the initial clinical evaluation. 70% of the patients who had wound dehiscence post-operatively developed ICI. Loculations and abscesses occurred only in patients who had surgical repair. A multivariate logistic regression analysis revealed that septic neural placode, hydrocephalus, a supra-lumbar location of the MMCs and surgical intervention were predictive of ICI (p < 0.05). CONCLUSION: Infection of the neural placode, hydrocephalus, locations of the lesions above the lumbar region, and surgical repair were the statistically significant risk factors for ICI in our study population. The trending but statistically insignificant risk factors for ICI in our series may require further assessment with a larger sample size.


Asunto(s)
Absceso Encefálico/epidemiología , Infecciones del Sistema Nervioso Central/epidemiología , Ventriculitis Cerebral/epidemiología , Meningitis/epidemiología , Meningomielocele/cirugía , Infección de la Herida Quirúrgica/epidemiología , Absceso Encefálico/complicaciones , Infecciones del Sistema Nervioso Central/complicaciones , Ventriculitis Cerebral/complicaciones , Pérdida de Líquido Cefalorraquídeo/epidemiología , Preescolar , Femenino , Humanos , Hidrocefalia/epidemiología , Hidrocefalia/cirugía , Lactante , Recién Nacido , Vértebras Lumbares , Región Lumbosacra , Masculino , Meningitis/complicaciones , Meningomielocele/complicaciones , Procedimientos Neuroquirúrgicos , Nigeria/epidemiología , Complicaciones Posoperatorias/epidemiología , Periodo Preoperatorio , Factores de Riesgo , Rotura Espontánea , Sacro , Dehiscencia de la Herida Operatoria/epidemiología , Vértebras Torácicas , Derivación Ventriculoperitoneal , Ventriculostomía
11.
Rinsho Shinkeigaku ; 59(3): 133-138, 2019 Mar 28.
Artículo en Japonés | MEDLINE | ID: mdl-30814444

RESUMEN

A 68-year-old man visited our hospital emergency department with consciousness disturbance. He was diagnosed as bacterial meningitis with septic shock, and initial empirical antibacterial therapy was initiated immediately. Streptococcus pneumoniae. was cultured from the cerebrospinal fluid (CSF), and brain MRIs showed pyogenic ventriculitis. Even though CSF findings improved, he was still in coma and finally died with pneumonia. It is unknown how pyogenic ventriculitis affects the course of bacterial meningitis. We analyzed total 11 inpatients with bacterial meningitis associated with or without the pyogenic ventriculitis, including the present patient, in our hospital. Severity of clinical symptoms and CSF findings might determine the duration of antimicrobial administration, regardless of whether pyogenic ventriculitis existed or not.


Asunto(s)
Antibacterianos/administración & dosificación , Ventriculitis Cerebral/complicaciones , Meningitis Neumocócica/complicaciones , Meningitis Neumocócica/tratamiento farmacológico , Anciano , Encéfalo/diagnóstico por imagen , Ventriculitis Cerebral/diagnóstico por imagen , Líquido Cefalorraquídeo/microbiología , Quimioterapia Combinada , Resultado Fatal , Humanos , Imagen por Resonancia Magnética , Masculino , Meningitis Neumocócica/diagnóstico , Meningitis Neumocócica/microbiología , Índice de Severidad de la Enfermedad , Streptococcus pneumoniae/aislamiento & purificación , Supuración
12.
Saudi Med J ; 39(9): 935-939, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-30251738

RESUMEN

To describe a fatal case of invasive Aspergillus flavus sinusitis in a 43-year old female with sickle cell disease (SCD) complicated by intracerebral aspergilloma and invasive Salmonella infection. Cerebral aspergilloma carries a very high mortality rate. The patient developed post-craniotomy intracerebral hemorrhage at the site of biopsy, Salmonella species sepsis and ventriculitis. She presented with a 2-month history of headache, dizziness, personality and behavioral changes, and vomiting. Initial clinical evaluation raised the suspicion of brain tumor. Brain magnetic resonance imaging revealed a left frontal, thick-walled ring-enhancing lesion with extensive surrounding edema suggestive of a neoplastic lesion, or a contiguous inflammatory or infectious process from the skull base. Despite early diagnosis and appropriate antifungal and surgical management, she eventually died from severe infection and respiratory arrest. In conclusion, invasive aspergillosis should be included in the differential diagnosis of SCD patients with central nervous system (CNS) lesions.


Asunto(s)
Anemia de Células Falciformes/complicaciones , Aspergillus flavus/aislamiento & purificación , Bacteriemia/complicaciones , Encefalopatías/complicaciones , Ventriculitis Cerebral/complicaciones , Neuroaspergilosis/complicaciones , Enfermedades de los Senos Paranasales/complicaciones , Infecciones por Salmonella/complicaciones , Adulto , Antifúngicos/uso terapéutico , Aspergillus flavus/patogenicidad , Bacteriemia/microbiología , Encefalopatías/diagnóstico por imagen , Encefalopatías/tratamiento farmacológico , Ventriculitis Cerebral/diagnóstico por imagen , Ventriculitis Cerebral/tratamiento farmacológico , Craneotomía/efectos adversos , Diagnóstico Diferencial , Resultado Fatal , Femenino , Humanos , Imagen por Resonancia Magnética , Neuroaspergilosis/diagnóstico por imagen , Neuroaspergilosis/tratamiento farmacológico , Enfermedades de los Senos Paranasales/microbiología , Complicaciones Posoperatorias/microbiología
15.
Neurol Sci ; 39(1): 79-84, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29027589

RESUMEN

The aim of the study is to explore the experiences in diagnosis and treatment of severe neurosurgical patients with pyogenic ventriculitis caused by gram-negative bacteria (G-). Nineteen patients with pyogenic ventriculitis were reviewed for their treatment. The bacterial testing results of cerebrospinal fluid (CSF), the clinical intervention, and the patients' prognosis were evaluated. The bacterial smears of ventricular drainage from all the cases were G- bacteria. Head CT and MRI scans confirmed that they were intraventricular empyema. Eighteen cases of CSF bacterial test were positive, including 12 cases of Acinetobacter baumannii positive, 2 of Klebsiella pneumonia positive, 2 of Serratia marcescens positive, 1 of Pseudomonas maltophila positive, and 1 case of Escherichia coli positive. One case of the bacterial culture was negative. All patients were treated by using intraventricular lavage in combination with intravenous and intraventricular antibiotics in accordance with the clinical conditions. After treatment for 2 to 8 weeks, 14 patients were cured (74%) and 5 were died (26%). Eight patients who were cured had received ventriculoperitoneal shunt due to hydrocephalus at 2 to 6 weeks after infection controlled, and none of them had any reinfection. Twelve of the 14 cured cases came to consciousness, but 2 were persistent in vegetative state starting before the infection; they did not show any improving consciousness after infection had been cured. Suppurative ventriculitis in severe neurosurgical patients is mainly infected by G- with a higher mortality. Early diagnosis, especially in identifying pathogen types, timely ventricular irrigation, and ventricular drainage together with intravenous and intraventricular antibiotic treatment, should improve prognosis.


Asunto(s)
Antibacterianos/uso terapéutico , Ventriculitis Cerebral/diagnóstico , Ventriculitis Cerebral/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/diagnóstico , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Procedimientos Neuroquirúrgicos/efectos adversos , Adulto , Anciano , Ventriculitis Cerebral/líquido cefalorraquídeo , Ventriculitis Cerebral/complicaciones , Preescolar , Femenino , Infecciones por Bacterias Gramnegativas/líquido cefalorraquídeo , Infecciones por Bacterias Gramnegativas/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/tratamiento farmacológico , Resultado del Tratamiento , Adulto Joven
16.
BMJ Case Rep ; 20172017 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-29025781

RESUMEN

Communicating hydrocephalus may complicate infantile bacterial meningitis, typically presenting with systemic features of infection. We report a rare case of 'subclinical meningoventriculitis' causing obstructive hydrocephalus and its challenging management. A healthy 10-week-old immunocompetent male patient presented with failure to thrive and vomiting, secondary to presumed gastro-oesophageal reflux. The child was neurologically alert, afebrile with normal inflammatory markers. Progressive macrocephaly prompted an MRI confirming triventricular hydrocephalus secondary to aqueductal stenosis. An endoscopic third ventriculostomy was performed however abandoned intraoperatively due to the unexpected finding of intraventricular purulent cerebrospinal fluid. A 6-week course of intravenous ceftriaxone was commenced for Escherichia coli meningoventriculitis. However, the child was readmitted 18 days postoperatively with acute hydrocephalus requiring a ventricular washout and staged ventriculoperitoneal shunt insertion at 4 weeks. Serial head circumference measurements are paramount in the assessment of a paediatric patient. In an immunocompetent child, a subclinical fibropurulent meningoventriculitis can result in several management challenges.


Asunto(s)
Antibacterianos/uso terapéutico , Ceftriaxona/uso terapéutico , Ventriculitis Cerebral/microbiología , Hidrocefalia/microbiología , Meningoencefalitis/microbiología , Politetrafluoroetileno/uso terapéutico , Infecciones Urinarias/terapia , Amoxicilina/uso terapéutico , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/terapia , Derivaciones del Líquido Cefalorraquídeo , Humanos , Hidrocefalia/etiología , Hidrocefalia/terapia , Recién Nacido , Inyecciones , Masculino , Meningoencefalitis/complicaciones , Meningoencefalitis/terapia , Resultado del Tratamiento , Uréter , Ventriculostomía
17.
Rev. esp. quimioter ; 30(5): 327-333, oct. 2017. tab
Artículo en Español | IBECS | ID: ibc-167149

RESUMEN

Introducción. Las complicaciones infecciosas relacionadas con el drenaje ventricular externo (CIRDVE) son un problema importante en las Unidades de Cuidados Intensivos (UCI) neuroquirúrgicos. El objetivo del estudio es conocer la incidencia de CIRDVE y analizar los factores implicados. Material y métodos. Estudio retrospectivo en una UCI polivalente de adultos de un hospital universitario de tercer nivel. Se incluyeron todos los pacientes con drenaje ventricular externo (DVE) excepto aquellos diagnosticados de una infección del sistema nervioso central previa al implante. Resultados. Se incluyeron 87 pacientes, 106 DVE. Diagnóstico previo más frecuente: hemorragia subaracnoidea (49,4%). Presentaron CIRDVE 31 pacientes con 32 DVE. La tasa de CIRDVE fue de 19,5 por mil días de catéter y de ventriculitis 14 por mil días de catéter. Presentaron CIRDVE el 31,6% de los pacientes y ventriculitis el 25,3%. Los pacientes con CIRDVE tuvieron más manipulaciones del DVE (2,0 ± 0,6 vs. 3,3 ± 1,0 p=0,02), reposicionamiento (0,1 ± 0,1 vs. 0,2 ± 0,1) y mayor estancia media en UCI y hospitalaria (29,8 ± 4,9 vs. 49,8 ± 5,2, p<0,01 y 67,4 ± 18,8 vs, 108,9 ± 30,2, p=0,02 respectivamente). Los DVE con CIRDVE tuvieron mayor permanencia, tanto al diagnóstico como a la retirada (12,6 ± 2,1 vs. 18,3 ± 3,6 y 12,6 ± 2,1 vs. 30,4 ± 7,3, p<0,01). No hubo diferencias en mortalidad. Conclusiones. Uno de cada 3 pacientes presentó CIRDVE. Los factores relacionados fueron el número de manipulaciones, el reposicionamiento del DVE y el tiempo de permanencia. Los pacientes con CIRDVE tuvieron estancia media en UCI y hospitalaria más larga pero sin incremento en la mortalidad (AU)


Introduction. Infectious complications related to external ventricular shunt (ICREVS) are a main problem in neurocritical intensive care units (ICU). The aim of the review is to assess the incidence of ICREVS and to analyse factors involved. Material and methods: Retrospective analysis, adult polyvalent ICU in a third level reference hospital. Patients carrying external ventricular shunt (DVE) were included. Those patients with central nervous system infection diagnosed prior DVE placement were excluded. Results: 87 patients were included with 106 DVE. Most common admittance diagnosis was subarachnoid haemorrhage (49.4%). 31 patients with 32 DVE developed an ICREVS. Infection rate is 19.5 per 1000 days of shunt for ICREVS and 14 per 1000 days for ventriculitis. 31.6% of the patients developed ICREVS and 25.3% ventriculitis. Patients who developed ICREVS presented higher shunt manipulations (2.0 ± 0.6 vs. 3.26 ± 1.02, p=0.02), shunt repositioning (0.1 ± 0.1 vs. 0.2 ± 0.1) and ICU and hospital stay (29.8 ± 4.9 vs 49.8 ± 5.2, p<0.01 y 67.4 ± 18.8 vs. 108.9 ± 30.2, p=0.02. Those DVE with ICREVS were placed for longer not only at infection diagnosis but also at removal (12.6 ± 2.1 vs. 18.3 ± 3.6 and 12.6 ± 2.1 vs. 30.4 ± 7.3 days, p<0.01). No difference in mortality was found. Conclusions. One out of three patients with a DVE develops an infection. The risk factors are the number of manipulations, repositioning and the permanency days. Patients with ICREVS had a longer ICU and hospital average stay without an increase in mortality (AU)


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Infección Hospitalaria/complicaciones , Factores de Riesgo , Profilaxis Antibiótica/métodos , Infecciones/epidemiología , Drenaje/efectos adversos , Infecciones Relacionadas con Catéteres/complicaciones , Sistema Nervioso Central , Sistema Nervioso Central/patología , Estudios Retrospectivos , 28599 , Ventriculostomía/métodos , Infecciones/tratamiento farmacológico , Hemorragia Subaracnoidea/complicaciones , Ventriculitis Cerebral/complicaciones , Indicadores de Morbimortalidad , Enfermedades del Sistema Nervioso/diagnóstico
18.
Rev Esp Quimioter ; 30(5): 327-333, 2017 Oct.
Artículo en Inglés, Español | MEDLINE | ID: mdl-28749123

RESUMEN

OBJECTIVE: Infectious complications related to external ventricular shunt (ICREVS) are a main problem in neurocritical intensive care units (ICU). The aim of the review is to assess the incidence of ICREVS and to analyse factors involved. METHODS: Retrospective analysis, adult polyvalent ICU in a third level reference hospital. Patients carrying external ventricular shunt (DVE) were included. Those patients with central nervous system infection diagnosed prior DVE placement were excluded. RESULTS: 87 patients were included with 106 DVE. Most common admittance diagnosis was subarachnoid haemorrhage (49.4%). 31 patients with 32 DVE developed an ICREVS. Infection rate is 19.5 per 1000 days of shunt for ICREVS and 14 per 1000 days for ventriculitis. 31.6% of the patients developed ICREVS and 25.3% ventriculitis. Patients who developed ICREVS presented higher shunt manipulations (2.0 ± 0.6 vs. 3.26 ± 1.02, p=0.02), shunt repositioning (0.1 ± 0.1 vs. 0.2 ± 0.1) and ICU and hospital stay (29.8 ± 4.9 vs 49.8 ± 5.2, p<0.01 y 67.4 ± 18.8 vs. 108.9 ± 30.2, p=0.02. Those DVE with ICREVS were placed for longer not only at infection diagnosis but also at removal (12.6 ± 2.1 vs. 18.3 ± 3.6 and 12.6 ± 2.1 vs. 30.4 ± 7.3 days, p<0.01). No difference in mortality was found. CONCLUSIONS: One out of three patients with a DVE develops an infection. The risk factors are the number of manipulations, repositioning and the permanency days. Patients with ICREVS had a longer ICU and hospital average stay without an increase in mortality.


Asunto(s)
Infecciones Relacionadas con Catéteres/epidemiología , Derivación Ventriculoperitoneal/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Infecciones Relacionadas con Catéteres/mortalidad , Infecciones Bacterianas del Sistema Nervioso Central/epidemiología , Infecciones Bacterianas del Sistema Nervioso Central/mortalidad , Ventriculitis Cerebral/complicaciones , Ventriculitis Cerebral/epidemiología , Ventriculitis Cerebral/terapia , Femenino , Mortalidad Hospitalaria , Humanos , Incidencia , Unidades de Cuidados Intensivos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , España/epidemiología , Hemorragia Subaracnoidea/complicaciones , Hemorragia Subaracnoidea/epidemiología , Hemorragia Subaracnoidea/terapia
19.
Intern Med ; 56(7): 853-859, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28381755

RESUMEN

A 73-year-old man was admitted to our hospital with disturbance of consciousness, fever and headache. Cerebrospinal fluid (CSF) analysis revealed pleocytosis with neutrophil predominance, increased protein and low glucose. CSF and blood cultures yielded negative results. Antibiotics and antituberculous drugs were started for meningitis. An antimycotic was also added. The patient died from transtentorial hernia 99 days after admission. Autopsy revealed meningitis, ventriculitis and brain abscess, and Nocardia araoensis was detected in pus from the left lateral ventricle. This appears to represent the first report of N. araoensis meningitis complicated by ventriculitis and brain abscess.


Asunto(s)
Absceso Encefálico/complicaciones , Ventriculitis Cerebral/complicaciones , Meningitis/complicaciones , Nocardiosis/complicaciones , Nocardia , Anciano , Antiinfecciosos/uso terapéutico , Absceso Encefálico/microbiología , Ventriculitis Cerebral/tratamiento farmacológico , Ventriculitis Cerebral/microbiología , Humanos , Masculino , Meningitis/tratamiento farmacológico , Meningitis/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...